Spinal Tech

Life Spine's division, Centric Medical, reported record revenue growth of its foot and ankle as well as biologics product lines.

Neurosurgery published a new article, "Relationship of American Spinal Injury Association Impairment Scale Grade to Post-injury Hospitalization and Costs in Thoracic Spinal Cord Injury."

Bioventus received FDA clearance for Durolane, a single injection hyaluronic acid device used for joint lubrication in the treatment of knee osteoarthritis pain.

Smith & Nephew signed a three year partnership with Imperial College London to develop enhanced surgical techniques relating to ligament function, biomechanics and knee soft tissue injuries.

Mainstay Medical announced its half year financial report and an update on its ReActiv8 clinical trial.

Mazor Robotics' shares reached a new 52-week high of $49.64 on Sept. 1.

ApiFix entered into an exclusive distribution agreement with Joint Solutions Alliance Corp. in Canada, according to MarketsInsider.

Jason Hannon will take the helm of Mainstay Medical Oct. 9, according to MarketsInsider.

Medtronic launched new long-term clinical studies to collect prospective data on posterolateral fusion and transforaminal lumbar interbody fusion procedures using Infuse Bone Graft. 

Here are six key notes on orthopedic and spine device companies from the past week.